http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101311318-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate | 2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101311318-B1 |
| titleOfInvention | Formulations include whey protein and hydrolysate to improve muscle recovery |
| abstract | The present invention relates to a formulation comprising a whey protein or a hydrolyzate of whey protein, which can inhibit TNFα expression in lipopolysaccharide stimulated macrophages in vitro. The present invention also provides the use of a formulation for attenuating a decrease in muscle function due to muscle damage, enhancing recovery from muscle damage, and / or for enhancing muscle force generation and a method of making the formulation. |
| priorityDate | 2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 405.